Study guide

9.5 Quantitative Health Risk Characterization: HQ, HI, and ELCR

CIH Certified Industrial Hygienist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The CIH Exam and How to Use This Guide

1.1 CIH Exam Format, Scoring, and Test-Day Logistics 1.2 Eligibility, Application Windows, Fees, and Certification Maintenance 1.3 The BGC Blueprint, Subject Areas, and a Calculation-First Study Plan

2 Chapter 2: Basic Science & Calculations

2.1 Gas Laws and Vapor Calculations 2.2 Unit Conversions: ppm, mg/m³, and Standard Temperature/Pressure 2.3 Fluid Mechanics and Airflow Fundamentals

3 Chapter 3: Air Sampling & Instrumentation

3.1 Active and Passive Air Sampling Strategies 3.2 Particulate and Aerosol Sampling 3.3 Direct-Reading Instruments and Calibration

4 Chapter 4: Analytical Chemistry & Lab Methods

4.1 Gas Chromatography and Mass Spectrometry 4.2 High-Performance Liquid Chromatography and Ion Chromatography 4.3 Spectroscopy and Elemental Analysis 4.4 Gravimetric, Microscopy, and Wet Chemical Methods 4.5 Laboratory Quality Assurance, Chain of Custody, and Desorption Efficiency

5 Chapter 5: Biostatistics & Epidemiology

5.1 Lognormal Distributions and Exposure Data Statistics 5.2 Upper Confidence Limits (UCL95) and Compliance Decision Rules 5.3 Epidemiological Study Designs and Measures of Association 5.4 Sampling Strategy: Sample Size, Power, and Worker Selection

6 Chapter 6: Toxicology & Biological Monitoring

6.1 Dose-Response Relationships and Points of Departure 6.2 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination 6.3 Aerosol Deposition, Clearance, and Respiratory Tract Dosimetry 6.4 Hepatic, Renal, Neurologic, and Hematologic Target Organ Toxicity 6.5 Pulmonary Toxicology, Carcinogenicity, and Reproductive Hazards 6.6 OEL Frameworks, Classifications, and Excursion Limits 6.7 Chemical Mixtures and Extended Work-Shift OEL Adjustments 6.8 Biological Exposure Indices (BEIs) and Biomonitoring

7 Chapter 7: Biohazards & Indoor Environmental Quality

7.1 Mold, Fungi, and Microbial Contaminants 7.2 Infectious Agents, Bloodborne Pathogens, and Biosafety Levels 7.3 Indoor Environmental Quality (IEQ) Investigations 7.4 Sanitation, Potable Water, and Personal Hygiene Programs

8 Chapter 8: Community Exposure & Environmental Health

8.1 Clean Air Act Framework, NAAQS, and New Source Review 8.2 Hazardous Air Pollutants, CEMS, and EPA Reference Methods 8.3 Atmospheric Stability, Lapse Rates, and Plume Morphology 8.4 Gaussian Plume Modeling, Plume Rise, and Environmental Fate 8.5 HAZWOPER Scope, Mandates, and Training Tiers 8.6 Protection Levels, Site Zoning, Incident Command, and Decontamination 8.7 Water Pollution, Hazardous Waste, and Community Right-to-Know

9 Chapter 9: Health Risk Analysis & Hazard Communication

9.1 GHS Hazard Classification: Health and Physical Hazard Criteria 9.2 GHS Labels, Safety Data Sheets, and Trade Secret Rules 9.3 The AIHA Exposure Assessment Strategy and Similar Exposure Groups 9.4 Qualitative Exposure Profiling and the AIHA Risk Matrix 9.5 Quantitative Health Risk Characterization: HQ, HI, and ELCR 9.6 NIOSH Occupational Exposure Banding 9.7 Risk Communication and Reporting to Affected Parties

10 Chapter 10: Industrial Ventilation Principles & LEV Design

10.1 Elimination, Substitution, Isolation, Containment, and Process Change 10.2 LEV Hood Taxonomy and Capture Velocity Selection 10.3 Hood Airflow Equations, Entry Losses, and Hood Static Pressure 10.4 Particulate Transport Aerodynamics and Duct Sizing 10.5 Duct Friction, Fitting Losses, and System Balancing 10.6 Fan Categories and Pressure Dynamics Across the Fan 10.7 System Curves, the Fan Laws, and Density Corrections

11 Chapter 11: General Ventilation, Air Cleaning & Diagnostics

11.1 Dilution Ventilation Principles and Steady-State Modeling 11.2 Transient Purging and Air Distribution Geometry 11.3 Particulate Air Cleaning: Cyclones, Baghouses, Scrubbers, and ESPs 11.4 Gaseous Emission Control and Air Cleaner Selection 11.5 Ventilation System Troubleshooting and Testing

12 Chapter 12: Noise Measurement & Hearing Conservation

12.1 Acoustic Physics and Decibel Mathematics 12.2 Sound Propagation, Octave Bands, and Frequency Weighting 12.3 Noise Dose Metrics and OSHA versus ACGIH Criteria 12.4 Exchange Rates, Extended Shifts, and Dosimetry Field Protocols 12.5 Engineering Noise Controls and Hearing Protector Attenuation 12.6 Hearing Conservation Programs and Standard Threshold Shifts 12.7 Hand-Arm and Whole-Body Vibration

13 Chapter 13: Thermal Stress Assessment & Control

13.1 Wet Bulb Globe Temperature (WBGT) and Heat Stress Indices 13.2 Heat-Related Disorders, Acclimatization, and Work/Rest Regimens 13.3 Cold Stress Evaluation and Wind Chill

14 Chapter 14: Ionizing Radiation Protection

14.1 Ionizing Radiation Physics and Radioactive Decay Kinetics 14.2 Radiation Units, Radiobiology, and Health Effects 14.3 ALARA, Stay-Time, and the Inverse Square Law 14.4 Shielding Physics, Material Selection, and Gamma Constants 14.5 Radiation Detection Instruments and Spectrometry 14.6 Personnel Dosimetry, Dose Limits, and Contamination Surveys

15 Chapter 15: Non-Ionizing Radiation & Laser Safety

15.1 The Non-Ionizing Spectrum and Static/ELF Field Exposures 15.2 Radiofrequency and Microwave Exposure: SAR, Standards, and Surveys 15.3 Ultraviolet, Visible, and Infrared Radiation Hazards 15.4 Laser Safety Classifications and Optical Density Calculations 15.5 Illumination, Lighting Design, and Visual Performance

16 Chapter 16: Non-Engineering Controls & Personal Protective Equipment

16.1 Respiratory Protection Programs and Assigned Protection Factors 16.2 Maximum Use Concentration, Oxygen Deficiency, and Breathing Air 16.3 Particulate Filters, Sorbent Cartridges, and Change Schedules 16.4 Respirator Fit Testing Protocols 16.5 Chemical Protective Clothing and Dermal Exposure Control

17 Chapter 17: Ergonomics & Workstation Design

17.1 Soft-Tissue Biomechanics and WMSD Pathophysiology 17.2 Ergonomic Risk Factors and Their Interaction Effects 17.3 The Revised NIOSH Lifting Equation 17.4 RULA, REBA, the Strain Index, and the ACGIH HAL TLV 17.5 Anthropometry and Workstation Geometry 17.6 VDT Workstations, Hand Tool Design, and Administrative Ergonomics

18 Chapter 18: Work Environments & Industrial Processes

18.1 Welding Fume Emissions, Metal Fume Fever, and Cr(VI)/Manganese Toxicology 18.2 Foundry Operations and Hot Work Fire Prevention 18.3 Vapor Degreasing, Pickling, Electroplating, and Cyanide Baths 18.4 Spray Coatings, Isocyanates, and Semiconductor Manufacturing 18.5 Confined Spaces and High-Hazard Industrial Operations 18.6 Asbestos, Lead, and Silica: Regulated Substance Programs 18.7 Abrasive Blasting and Surface Preparation

19 Chapter 19: IH Program Management & Professional Ethics

19.1 The BGC Code of Ethics: Canons and Enforcement 19.2 Professional Liability, Standard of Care, and Expert Testimony 19.3 Occupational Health & Safety Management Systems (ISO 45001, ANSI Z10) 19.4 Exposure Records Access and Medical Surveillance 19.5 OSHA Injury and Illness Recordkeeping and Enforcement

9.5 Quantitative Health Risk Characterization: HQ, HI, and ELCR

Key Takeaways Explain This Topic AI

Risk assessment follows four steps: hazard identification, dose-response assessment, exposure assessment, and risk characterization.

For non-cancer endpoints the hazard quotient is average daily dose divided by the reference dose; an HQ above 1.0 indicates potential concern, and hazard quotients for agents affecting the same target organ are summed into a hazard index.

For carcinogens, excess lifetime cancer risk is the lifetime average daily dose multiplied by the cancer slope factor, or the air concentration multiplied by the inhalation unit risk.

Regulatory acceptability for carcinogens is typically framed between 1 in 10,000 and 1 in 1,000,000 excess lifetime risk, with 1 in 1,000,000 the common point of departure for environmental decisions.

Last updated: August 2026

Quantitative Health Risk Characterization: HQ, HI, and ELCR

Industrial hygienists must routinely make critical risk management decisions in complex chemical environments. While traditional compliance relies on comparing measured workplace airborne concentrations against established Occupational Exposure Limits (OELs) —such as OSHA Permissible Exposure Limits (PELs) or ACGIH Threshold Limit Values (TLVs)—authoritative OELs exist for fewer than 1,000 of the more than 85,000 chemicals currently registered in commercial trade under the Toxic Substances Control Act (TSCA).

To bridge this massive regulatory gap, modern occupational health practice integrates two rigorous scientific frameworks: Quantitative Human Health Risk Assessment (deriving Hazard Quotients, Hazard Indices, and Excess Lifetime Cancer Risks) and the NIOSH Occupational Exposure Banding (OEB) Process .

1. Quantitative Human Health Risk Assessment Framework

In 1983, the National Research Council (NRC) published Risk Assessment in the Federal Government: Managing the Process (the seminal "Red Book"), establishing the four-step paradigm adopted by the EPA, OSHA, and international health bodies: +-------------------------------------------------------------------------+

  • | NRC / EPA 4-STEP RISK ASSESSMENT PARADIGM |
  • +-------------------------------------------------------------------------+
  • | |
  • | [ 1. HAZARD IDENTIFICATION ] |
  • | - Identifies biological endpoints (carcinogenicity, hepatotoxicity) |
  • | - Synthesizes epidemiological, animal bioassay, and in vitro data |
  • | - Weight of Evidence (WoE) evaluation |
  • | | |
  • | v |
  • | [ 2. DOSE-RESPONSE ASSESSMENT ] |
  • | - Establishes Point of Departure (NOAEL, LOAEL, BMDL10) |
  • | - Applies Uncertainty Factors (UFs) to derive RfD / RfC |
  • | - Derives Cancer Slope Factor (CSF) & Inhalation Unit Risk (IUR) |
  • | | |
  • | v |
  • | [ 3. EXPOSURE ASSESSMENT ] |
  • | - Quantifies chemical concentration (C) in environmental media |
  • | - Calculates Average Daily Dose (ADD) & Lifetime ADD (LADD) |
  • | - Evaluates duration (ED), frequency (EF), intake rate (IR), body mass |
  • | | |
  • | v |
  • | [ 4. RISK CHARACTERIZATION ] |
  • | - Non-Cancer: Hazard Quotient (HQ) & Mixture Hazard Index (HI) |
  • | - Cancer: Excess Lifetime Cancer Risk (ELCR = LADD x CSF) |
  • | - Explicit evaluation of uncertainties, assumptions, and limitations |
  • +-------------------------------------------------------------------------+
  • 2. Non-Cancer Risk Characterization: ADD, RfD, HQ, and HI

Non-carcinogenic toxicity operates under a threshold model : biological homeostatic reserves and cellular repair mechanisms prevent adverse effects until a critical threshold dose is exceeded.

2.1 Average Daily Dose (ADD) & Inhalation Exposure Concentration (EC)

For oral or dermal exposures, the Average Daily Dose (ADD) is calculated as: A D D = C × I R × E D × E F B W × A T n c ADD = \frac{C \times IR \times ED \times EF}{BW \times AT_{nc}} A DD = B W × A T n c ​ C × I R × E D × EF ​

For inhalation exposures, the time-weighted Exposure Concentration (EC) is expressed as: E C = C a i r × E T × E F × E D A T n c EC = \frac{C_{air} \times ET \times EF \times ED}{AT_{nc}} EC = A T n c ​ C ai r ​ × ET × EF × E D ​

Where:

  • C = Contaminant concentration in medium (mg/L, mg/kg, or mg/m³)
  • IR = Intake rate (e.g., adult drinking water intake 2 L/day, inhalation rate 20 m³/day)
  • ET = Exposure time (hours/day)
  • EF = Exposure frequency (days/year, e.g., 250 days/year for occupational exposure)
  • ED = Exposure duration (years, e.g., 25--30 years working lifetime)
  • BW = Body weight (standard adult reference mass = 70 kg or 80 kg)
  • ATnc = Averaging time for non-carcinogens (ED × 365 days/year × 24 hours/day)
  • 2.2 Reference Dose (RfD) and Reference Concentration (RfC)

The Reference Dose (RfD) (or inhalation Reference Concentration, RfC ) is an estimate of a continuous daily exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious non-cancer effects during a lifetime: R f D = NOAEL (or BMDL 10 ) ∏ UF = NOAEL U F A × U F H × U F S × U F L × U F D RfD = \frac{\text{NOAEL (or } \text{BMDL}_{10}\text{)}}{\prod \text{UF}} = \frac{\text{NOAEL}}{UF_A \times UF_H \times UF_S \times UF_L \times UF_D} R f D = ∏ UF NOAEL (or BMDL 10 ​ ) ​ = U F A ​ × U F H ​ × U F S ​ × U F L ​ × U F D ​ NOAEL ​

2.3 Hazard Quotient (HQ)

The Hazard Quotient (HQ) is the ratio of the estimated site-specific exposure to the health-protective reference benchmark: H Q = A D D R f D or H Q = E C R f C \mathbf{HQ = \frac{ADD}{RfD}} \quad \text{or} \quad \mathbf{HQ = \frac{EC}{RfC}} HQ = RfD ADD ​ or HQ = RfC EC ​

HQ ≤ 1.0: Exposure is acceptable ; adverse non-carcinogenic health effects are unlikely to occur.

HQ > 1.0: Exposure exceeds the reference safety benchmark; potential for adverse toxicological effects exists (risk increases as HQ increases, though HQ is not a direct linear probability).

2.4 Hazard Index (HI) for Chemical Mixtures

Workplace exposures rarely involve single isolated chemicals. When workers are exposed simultaneously or sequentially to multiple chemicals affecting the same toxicological target organ or physiological mechanism (dose additivity), the individual Hazard Quotients are summed to calculate the Hazard Index (HI) : H I = ∑ i = 1 n H Q i = C 1 R f C 1 + C 2 R f C 2 + ⋯ + C n R f C n \mathbf{HI = \sum_{i=1}^{n} HQ_i = \frac{C_1}{RfC_1} + \frac{C_2}{RfC_2} + \dots + \frac{C_n}{RfC_n}} HI = i = 1 ∑ n ​ H Q i ​ = Rf C 1 ​ C 1 ​ ​ + Rf C 2 ​ C 2 ​ ​ + ⋯ + Rf C n ​ C n ​ ​ +-------------------------------------------------------------------------+

  • | TARGET ORGAN SEGREGATION OF HAZARD INDICES |
  • +-------------------------------------------------------------------------+
  • | |
  • | TOTAL CHEMICAL MIXTURE: Solvents A, B, C, D, E |
  • | |
  • | [ STEP 1: Calculate Gross HI ] |
  • | HI_gross = HQ_A + HQ_B + HQ_C + HQ_D + HQ_E |
  • | - If HI_gross <= 1.0 -> ALL EXPOSURES ACCEPTABLE |
  • | - If HI_gross > 1.0 -> PROCEED TO TARGET ORGAN SEGREGATION |
  • | |
  • | [ STEP 2: Segregate by Toxicological Target Organ / MOA ] |
  • | - HEPATOTOXIC HI = HQ_A (CCl4) + HQ_B (Chloroform) |
  • | - NEUROTOXIC HI = HQ_C (Toluene) + HQ_D (Xylene) |
  • | - NEPHROTOXIC HI = HQ_E (Cadmium) |
  • | |
  • | [ STEP 3: Evaluate Each Segregated HI Against 1.0 ] |
  • | - If any Target Organ HI > 1.0 -> UNACCEPTABLE ORGAN-SPECIFIC RISK |
  • +-------------------------------------------------------------------------+

Exam Key Concept — Target Organ Segregation: Summing HQs across unrelated toxicological mechanisms (e.g., adding an ototoxic acoustic trauma agent to a nephrotoxin) can artificially inflate the Hazard Index. If the gross HI > 1.0, the industrial hygienist must segregate chemicals by specific target organ (e.g., liver, central nervous system, kidney, respiratory tract). If any target-organ-specific HI > 1.0, the combined exposure is unacceptable .

3. Carcinogenic Risk Characterization: LADD, CSF, IUR, and ELCR

For genotoxic carcinogens, toxicologists assume a Linear No-Threshold (LNT) model: every molecule of exposure carries a non-zero probability of interacting with DNA to induce neoplastic transformation.

3.1 Lifetime Average Daily Dose (LADD)

Because cancer risk is modeled across an entire lifetime, exposures occurring during working years must be averaged over a full theoretical lifespan (typically assumed to be 70 years or 25,550 days): L A D D = C × I R × E F × E D B W × A T c \mathbf{LADD = \frac{C \times IR \times EF \times ED}{BW \times AT_c}} LADD = BW × A T c ​ C × IR × EF × ED ​

Where:

  • ATc = Averaging time for carcinogens = 70 years × 365 days/year = 25,550 days
  • 3.2 Cancer Slope Factor (CSF) & Inhalation Unit Risk (IUR)

Cancer Slope Factor (CSF, oral/dermal): The upper-bound 95% confidence limit on the slope of the linearized dose-response curve in the low-dose region, expressed in units of (mg/kg/day)⁻¹ .

Inhalation Unit Risk (IUR): The upper-bound excess lifetime cancer risk resulting from continuous lifetime exposure to an airborne concentration of 1 µg/m³, expressed in units of (µg/m³)⁻¹ .

3.3 Excess Lifetime Cancer Risk (ELCR) Quantification ELCR = L A D D × C S F or ELCR = C a i r × I U R \mathbf{\text{ELCR} = LADD \times CSF} \quad \text{or} \quad \mathbf{\text{ELCR} = C_{air} \times IUR} ELCR = LADD × CSF or ELCR = C air ​ × IUR

For multi-carcinogen exposures, cancer risks are assumed to be additive: Total Cancer Risk = ∑ i = 1 m ELCR i \text{Total Cancer Risk} = \sum_{i=1}^{m} \text{ELCR}_i Total Cancer Risk = i = 1 ∑ m ​ ELCR i ​

Regulatory Benchmark Risk Levels

10⁻⁶ (1 in 1,000,000): Traditional de minimis risk level used by the EPA for public health and ambient environmental standards.

10⁻⁴ (1 in 10,000): Upper ceiling of the EPA acceptable risk range (10⁻⁶ to 10⁻⁴) and common benchmark utilized in occupational risk frameworks (e.g., OSHA significant risk determinations under the Benzene and Inorganic Arsenic standards).